Ftse Mib
34.465,68
-0,40%
DAX
18.680,20
-0,25%
S&P 500
5.289,15
-0,61%
NASDAQ
16.726,71
-0,63%
Bitcoin
69.554,09
-0,82%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Shuttle Pharmaceuticals Holdings Inc (SHPH) Shuttle Pharmaceuticals Holdings Inc (SHPH) Notizie

Shuttle Pharmaceuticals Holdings Inc

SHPH
0,425501
-0,0025 (-0,58%)
Ultimo aggiornamento: 19:40:44
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/5/202415:00EDGAR2Form 8-K - Current report
14/5/202415:00GLOBEShuttle Pharma Provides First Quarter 2024 Corporate Update
13/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/4/202422:15GLOBEShuttle Pharmaceuticals to Present at the Planet MicroCap..
22/3/202414:00PRNUSShuttle Pharma Provides Fourth Quarter 2023 Corporate Update
09/3/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:00EDGAR2Form 8-K - Current report
13/2/202414:00EDGAR2Form 8-K - Current report
13/2/202414:00PRNUSShuttle Pharma Announces Its Intent to Pursue a Rights..
05/2/202422:25EDGAR2Form 8-K - Current report
23/1/202422:30PRNUSShuttle Pharma to Participate in a Fireside Chat at the..
08/1/202415:05EDGAR2Form 8-K - Current report
08/1/202415:00PRNUSShuttle Pharmaceuticals Receives FDA Approval to Proceed..
02/1/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202303:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:10EDGAR2Form 8-K - Current report
11/12/202315:00EDGAR2Form 8-K - Current report
11/12/202315:00PRNUSShuttle Pharmaceuticals Submits IND Application to the U.S...
30/11/202315:00EDGAR2Form 8-K - Current report
14/11/202315:00PRNUSShuttle Pharmaceuticals Provides Third Quarter 2023..
13/11/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202314:00PRNUSShuttle Pharma Advances Prostate Cancer Predictive Biomarker..
30/10/202322:14EDGAR2Form 8-K - Current report
20/10/202322:15EDGAR2Form ARS - Annual Report to Security Holders
20/10/202322:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202315:00EDGAR2Form 8-K - Current report
10/10/202315:00PRNUSShuttle Pharma to Participate in the Lytham Partners Fall..
05/10/202322:10EDGAR2Form 8-K - Current report
25/9/202315:00EDGAR2Form 8-K - Current report
25/9/202315:00PRNUSShuttle Pharma Announces Results of Pre-IND Meeting with FDA..
13/9/202315:00PRNUSShuttle Pharma Participates in Hampton University Proton..
11/9/202315:00PRNUSShuttle Pharma Expands Patent Coverage on HDAC Inhibitor..
07/9/202315:20EDGAR2Form 8-K - Current report
29/8/202315:00PRNUSShuttle Pharma's Selective HDAC6 Inhibitor Shown to..
24/8/202320:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/8/202301:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:00EDGAR2Form 8-K - Current report
15/8/202315:00PRNUSShuttle Pharmaceuticals Provides Second Quarter 2023..
14/8/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:00EDGAR2Form 8-K - Current report
03/8/202315:00PRNUSShuttle Pharmaceuticals Completes Manufacturing of Active..
26/5/202315:00PRNUSShuttle Pharmaceuticals Provides First Quarter 2023..
Apertura: 0,419 Min: 0,410001 Max: 0,429
Chiusura: 0,428

La tua Cronologia

NASDAQ
SHPH
Shuttle Pharmaceuticals
TSXV
CYON.H
Cyon Exploration
NASDAQ
DDICD
Ddi
BIT
S30149
Societe Generale Effekten
ASX
CSS
Clean Seas Seafood
BIT
P1QJR2
BNP Paribas Issuance
BIT
UB3YG9
Unicredit Bank
LSE
KEF
NYSE
NXRTW
USOTC
LNTQF
Leonteq (PK)
GATE
SWAYUSDT
Sway Social Protocol
NASDAQ
NKEQ
AXS 2X NKE Bear Daily ETF
TG
CLB
Christina Lake Cannabis
BIT
USFMD
UBS ETF IE MSCI USA Sele...
BIT
1MTX
MTU Aero Engines
NYSE
GAPA
G&P Acquisition
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network